UV
Umesh Vinayakrao Barabde
About Umesh Vinayakrao Barabde
Data last updated:
Umesh Vinayakrao Barabde has 2 years in corporate governance. Holds Director role. Currently with 1 company, including Neovant Therapeutics Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Neovant Therapeutics Private Limited at ₹2.66 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Dec 2023 | 2023 | ₹2.66 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Umesh Vinayakrao Barabde
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Umesh Vinayakrao Barabde
Umesh Vinayakrao Barabde has 2 years in corporate governance. Holds Director role. Currently with 1 company, including Neovant Therapeutics Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Neovant Therapeutics Private Limited at ₹2.66 Cr (FY 2025).
Umesh Vinayakrao Barabde is associated with 1 company as Director, including Neovant Therapeutics Private Limited (₹2.66 Cr).
Umesh Vinayakrao Barabde has expertise in General Business.
Umesh Vinayakrao Barabde has 2 years in corporate governance.
By reported revenue, the largest current company of Umesh Vinayakrao Barabde is Neovant Therapeutics Private Limited, with revenue of ₹2.66 Cr (FY 2025).
Umesh Vinayakrao Barabde currently holds positions at 1 company: Neovant Therapeutics Private Limited (₹2.66 Cr).